NEW YORK (Reuters Health) Jul 16 – Lyme disease vaccine is cost effective only in the uncommon situation in which an individual is frequently exposed to ticks in a Lyme disease-endemic area, according to a report in the June issue of Arthritis & Rheumatism.
The high cost of the Lyme disease vaccine and the low risk of Lyme disease in most areas suggested to the authors the need for a cost-effectiveness analysis of the vaccine and an examination of the factors influencing its cost effectiveness.
Dr. Elizabeth Hsia and colleagues from University of Pennsylvania in Philadelphia performed a decision analysis of the cost effectiveness of Lyme disease vaccine under different assumptions of disease incidence and vaccine cost.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!